Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 6 minute read Pharma Industry News Klotho Neurosciences begins manufacturing KLTO-202 gene therapy to advance clinical trials in ALS Klotho Neurosciences begins KLTO-202 manufacturing to prepare for ALS clinical trials, with a gene therapy targeting neuroprotection in spinal neurons. byPallavi MadhirajuJuly 1, 2025